-
Sodium dicloxacillin monohydrate: Assay Guide
2026-09-04
Sodium dicloxacillin monohydrate is a focused tool for MSSA and Gram-positive bacterial infection research. This guide connects β-lactam pharmacology with analytical assay selection, explaining how to interpret potency, compartment effects, formulation chemistry, and translational limitations.
-
Gepotidacin Versus Nitrofurantoin in UTI Trials
2026-09-04
The EAGLE-2 and EAGLE-3 phase 3 trials evaluated oral gepotidacin, also known as GSK2140944, against nitrofurantoin for uncomplicated urinary tract infection. Gepotidacin met the prespecified non-inferiority criterion in both studies and was superior to nitrofurantoin in EAGLE-3, supporting clinical development of an oral antibiotic with a distinct bacterial topoisomerase pathway target.
-
Gepotidacin: Practical Antibacterial Workflows
2026-09-03
Gepotidacin, also known as GSK2140944, gives antibacterial research teams a mechanistically distinct way to investigate bacterial DNA replication inhibition and resistant pathogens. This workflow-focused guide covers assay setup, concentration design, translational interpretation, and troubleshooting for reproducible studies.
-
Nadolol (SQ-11725) Assay Workflows
2026-09-03
Nadolol (SQ-11725) provides a practical non-selective beta-receptor blockade tool for cardiovascular signaling, transporter, and pharmacokinetic assays. This workflow-focused guide shows how to separate receptor effects from exposure variability and adapt disease-state PK lessons from recent MASH research without overextending the evidence.
-
Prednisone: Mechanism, Evidence, and Workflows
2026-09-02
Prednisone is a synthetic corticosteroid used in research on lymphocyte suppression, apoptosis, neurodegeneration, and corticosteroid pharmacology. Its reported profile combines G1-phase arrest, IL-2 pathway suppression, dose- and time-dependent apoptosis, and defined DMSO handling requirements.
-
Bacitracin (B1670) Workflow and QC Guide
2026-09-02
Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers solvent selection, storage, assay controls, and troubleshooting, but the product is not intended for diagnostic, clinical, or medical use.
-
L-NAME Hydrochloride: NOS Inhibition Guide
2026-09-01
L-NAME Hydrochloride, also called NG-nitro-L-arginine methyl ester hydrochloride, is a competitive nitric oxide synthase inhibitor for mechanistic research. The compound supports vascular tone regulation studies, hypertension research, and controlled analysis of nitric oxide and inflammatory signaling.
-
Stattic Workflow for STAT3 Inhibition Research
2026-08-31
Stattic provides a practical way to test whether STAT3 dimerization, phosphorylation, and nuclear signaling drive a phenotype. This workflow connects HNSCC radiosensitization with a carefully bounded lymphatic endothelial-cell application inspired by recent pathway research.
-
(S)-Mephenytoin in Intestinal Organoid Assays
2026-08-31
Discover how (S)-Mephenytoin can function as a CYP2C19 substrate probe in human iPSC-derived intestinal organoid workflows. This guide focuses on assay architecture, metabolite interpretation, and the practical limits of translating organoid CYP activity into pharmacokinetic evidence.
-
Cefepime (BMY-28142) in Viability Assays
2026-08-30
Learn how Cefepime (BMY-28142), SKU BA1013, can be integrated into bacterial infection models without confusing antimicrobial effects with host-cell viability. This scenario-based guide covers assay compatibility, fresh-solution handling, interpretation, and practical product selection.
-
Ceftolozane/Tazobactam: Innovation and Evidence
2026-08-29
This review evaluates ceftolozane/tazobactam as an antipseudomonal cephalosporin and beta-lactamase inhibitor combination designed to address resistant gram-negative infections. Its key contribution is the integration of mechanism, resistance activity, pharmacokinetics, pharmacodynamics, clinical trial evidence, and safety data into a framework for interpreting its use in complicated intraabdominal and urinary tract infections.
-
Sodium Citrate for Reproducible SERS Assays
2026-08-29
Sodium citrate can provide a controllable chemical environment for SERS assay development, but its effects on plasmonic assembly must be separated from the geometry of the substrate. This article translates a 3D gold nanocluster study into a practical framework for buffer, chelation, protein-matrix, and reproducibility decisions.
-
THBS1 in Laryngeal Cancer: Evidence and Methods
2026-08-28
The reference study combines transcriptomic cohorts, machine-learning feature selection, immune-pathway analysis, and cell-based assays to identify THBS1 as a prognostic and functionally relevant factor in laryngeal cancer. Its results connect THBS1 with epithelial-to-mesenchymal transition, integrin signaling, lipid metabolism, immune suppression, and a possible clopidogrel-related therapeutic vulnerability, while highlighting the need for clinical validation.
-
NF 449: Selective Purinergic Receptor Antagonist
2026-08-28
NF 449 is a receptor subtype-selective tool for separating ATP-driven P2X1 signaling from P2Y1 and P2Y12 responses in platelet experiments. This guide translates its receptor pharmacology into practical workflows for platelet activation studies, collagen assays, thrombosis models, and troubleshooting.
-
AG-126: A Decision Framework for ERK Studies
2026-08-27
AG-126 and Tyrphostin AG-126 provide a focused way to test whether ERK1/2 signaling contributes to inflammation and striatal circuit phenotypes. This article presents an evidence-calibrated assay framework that separates ERK causality from PKC-driven neuronal mechanisms.